Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

Bullboard (CSE:AGN)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Post by biggonadson Jul 27, 2022 12:20pm

$25 PT for AGN = 8 bagger alert

Following up to the recently announced, positive results from AGN’s positive results from phase 2a studies, definitely welcome results on their breakthrough therapy they’re developing. At current ...more  
107
Post by partystockeron Jul 26, 2022 4:11pm

BIG study results from AGN.c

These stage 2a study results from Algernon Pharmaceuticals (CSE: AGN) are very promising. In this phase of the company’s proof of concept study using Ifenprodil to treat IPF and chronic cough, it ...more  
139
Post by waves1on Jul 26, 2022 3:53pm

IPF's orphan disease indication beneficial to AGN

More on Algernon's ($AGN.c $AGNPF) Phase 2a study of Ifenprodil: https://themarketherald.ca/crossing-the-finish-line-algernon-cseagn-reaches-endpoint-in-phase-2a-study-of-ifenprodil-2022-07-22 ...more  
88
Post by Justdosomeddon Jul 25, 2022 1:45pm

Statistical Significance in the IPF Study

With $AGN.C’s latest topline data release, things are starting to look good for the company. I want to especially focus on the IPF trial as it recently hit the phase 2 co-primary endpoint here. It’s ...more  
109
Post by StockHawk1on Jul 22, 2022 7:36pm

News from AGN's Ifenprodil proof of concept study

Algernon Pharmaceuticals Inc. (AGN.c $AGNPF) recently announced that it has met the co-primary endpoint in its Phase 2 proof of concept study evaluating its drug, Ifenprodil, for the potential ...more  
175
Post by StockHawk1on Jul 22, 2022 7:30pm

News for AGN's proof of concept study evaluating its IP Fibr

The pharmaceutical development company Algernon Pharmaceuticals Inc. (AGN.c $AGNPF) recently announced that it has met the co-primary endpoint in its Phase 2 proof of concept study evaluating its drug ...more  
123
Post by biggonadson Jul 22, 2022 12:20pm

Prime high-risk/high-reward opportunity

Algernon pharmaceuticals presents a compelling high-risk/high-reward opportunity - highly undervalued (market cap ~$6M). Recently releasing positive topline data from their ifenprodil phase 2 study ...more  
130
Discussion
Post by waves1on Jul 21, 2022 2:41pm

AGN CEO discussing IPF & chronic cough study results

Algernon Pharmaceuticals ($AGN.c $AGNPF) CEO on Proactive ...more  
99
Post by waves1on Jul 20, 2022 6:42pm

AGN is new on my radar but I'm liking the potential!

Algernon Pharmaceuticals ($AGN.c $AGNPF) recently came onto my radar following the Market Herald's Power Play interview with Chris Moreau and I'm quite intrigued by its business model and ...more  
118
Discussion
Post by nodaytraderon Jul 19, 2022 2:05pm

Price Decline

Here we go again! very good news from the company followed by a rise in price, then a series of mini trades to drag the price down. Economically speaking, the price of a commodity is what someone ...more  
135
Post by Justdosomeddon Jul 19, 2022 1:25pm

Ifenprodil Phase 2 Data / Hitting Co-Primary Endpoint

$AGN.C just announced positive topline data showing that it has met the co-primary endpoint in its Phase 2 proof of concept study evaluating Ifenprodil for the potential treatment of idiopathic ...more  
109
Comment by TheBearInTheWoodson Jul 18, 2022 11:34pm

RE:$25 Price Target Screenshot

The company that just raised at all time lows, after taking commission and a warrant initiate coverage. Can't believe retail fall for this. Mackie also raised at $35 and $25 then stopped coverage ...more  
113
Discussion
Post by SkynetMoneyon Jul 18, 2022 3:42pm

$25 Price Target Screenshot

Heres a link to the screenshot that a user posted on CEO.ca   https://ceo.ca/agn?6f18f4e997b2  
146
Discussion
Comment by SkynetMoneyon Jul 18, 2022 3:32pm

RE:New Analyst update calling AGN.C a SPEC BUY with $25 target

Screenshot didnt work   Breathing Easier - Liftoff! - IPF Phase 2a Data Hits ACTION: Maintaining SPECULATIVE BUY Rating and Target Price AGN reported topline results of a Phase 2a trial with ...more  
82
Discussion
Post by SkynetMoneyon Jul 18, 2022 3:29pm

New Analyst update calling AGN.C a SPEC BUY with $25 target

New Analyst update calling AGN.C a SPEC BUY with $25 target   Here's a screenshot from my broker this morining... Could bring lots of attention   
113
Discussion
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next